220
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Foetal and maternal outcomes in hyperuricaemia pre-eclampsia patients in Hospital Universiti Sains Malaysia

, , , , , , , , & show all

References

  • Asgharnia M, Mirblouk F, Kazemi S, Pourmarzi D, Mahdipour Keivani M, Dalil Heirati S. 2017. Maternal serum uric acid level and maternal and neonatal complications in preeclamptic women: a cross-sectional study. International Journal of Reproductive BioMedicine 15:583–588.
  • Bainbridge S, Roberts J. 2008. Uric acid as a pathogenic factor in preeclampsia. Placenta 29:67–72.
  • Clark B, Halvorson L, Sachs B, Epstein F. 1992. Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. American Journal of Obstetrics and Gynecology 166:962–968.
  • D’Anna R, Baviera G, Scilipoti A, Leonardi I, Leo R. 2000. Clinical utility of serum uric acid measurements in pre-eclampsia and transient hypertension in pregnancy. Panminerva Medica 42:1–3.
  • Duley L. 2009. The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology 33:130–137.
  • Evans T. 1955. Endogenous creatinine clearance as a measure of renal function in normal and toxemic pregnancies. American Journal of Obstetrics and Gynecology 70:122–134.
  • Fay R. 1990. Uric acid in pregnancy and preeclampsia: an alternative hypothesis. The Australian and New Zealand Journal of Obstetrics and Gynaecology 30:141–142.
  • Feig D, Nakagawa T, Ananth Karumanchi S, Oliver W, Kang D, Finch J, Johnson R. 2004. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney International 66:281–287.
  • Hawkins T, Roberts J, Mangos G, Davis G, Roberts L, Brown M. 2012. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. BJOG 119:484–492.
  • Hussain S, Choudhury M, Akhter J, Begum S, Mowsumi F, Azad M. 2012. Fetal outcome of pre-eclamptic mothers with hyperuricemia. Journal of Dhaka National Medical College & Hospital 17:41–43.
  • Khaleeq A, Waheed K, Ejaz S, Kamal A. 2015. Hyperuricemia as a predictor of poor fetal outcome in pre-eclamptic women. Journal of Rawalpindi Medical College 19:171–173.
  • Lind T, Godfrey K, Otun H, Philips P. 1984. Changes in serum uric acid concentrations during normal pregnancy. BJOG 91:128–132.
  • Odendaal HJ, Pienaar ME. 1997. Are high uric acid levels in patients with early pre-eclampsia an indication for delivery? South African Medical Journal 87:213–218.
  • Roberts J, Bodnar L, Lain K, Hubel C, Markovic N, Ness R, Powers R. 2005. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 46:1263–1269.
  • Sagen N, Haram K, Nilsen ST. 1984. Serum urate as a predictor of fetal outcome in severe pre-eclampsia. Acta Obstetricia et Gynecologica Scandinavica 63:71–75.
  • Thangaratinam S, Ismail K, Sharp S, Coomarasamy A, Khan K. 2006. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG 113:369–378.
  • Tshibuela BD, Kayembe NN, Muwonga MJ, Nganga NK, Ngole N, Elongi JP. 2017. Relationship between uricemia and other biochemical markers with the materno-fetal complications during pre-eclampsia. Open Journal of Obstetrics and Gynecology 7:1255–1261.
  • Varma T. 1982. Serum uric acid levels as an index of fetal prognosis in pregnancies complicated by pre-existing hypertension and pre-eclampsia of pregnancy. International Journal of Gynecology & Obstetrics 20:401–408.
  • Voto L, Illia R, Darbon-Grosso H, Imaz F, Margulies M. 1988. Uric acid levels: a useful index of the severity of preeclampsia and perinatal prognosis. Journal of Perinatal Medicine 16:123–126.
  • Wu Y, Xiong X, Fraser W, Luo Z. 2012. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies. American Journal of Hypertension 25:711–717.
  • Yassaee F. 2003. Hyperuricemia and perinatal outcomes in patients with severe preeclampsia. Iranian Journal of Medical Sciences 28:198–199.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.